Interferon and Ribavirin vs Interferon Alone in the Re-treatment of Chronic Hepatitis C Previously Nonresponsive to Interferon
Data up to Jan 2025
Total Citations Per Year
Abstract
References (44)
Meta-analysis in clinical trials
1986 • 36,193 citations
Interferon Alfa-2b Alone or in Combination with Ribavirin as Initial Treatment for Chronic Hepatitis C
1998 • 3,550 citations
Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis
1981 • 3,549 citations
The Prevalence of Hepatitis C Virus Infection in the United States, 1988 through 1994
1999 • 3,083 citations
Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus
1998 • 2,374 citations
Hepatitis C
1994 • 1,906 citations
Summing up: The Science of Reviewing Research
1987 • 1,530 citations
A method for assessing the quality of a randomized control trial
1981 • 1,370 citations
Interferon Alfa-2b Alone or in Combination with Ribavirin for the Treatment of Relapse of Chronic Hepatitis C
1998 • 1,318 citations
Recommendations for Prevention and Control of Hepatitis C Virus (HCV) Infection and HCV-Related Chronic Disease
1998 • 1,246 citations
Clinical Outcomes after Transfusion-Associated Hepatitis C
1995 • 1,228 citations
The Treatment of Chronic Viral Hepatitis
1997 • 974 citations
Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: Effects of dose and duration
1996 • 675 citations
Incorporating variations in the quality of individual randomized trials into meta-analysis
1992 • 649 citations
National Institutes of Health Consensus Development Conference Panel statement: Management of hepatitis C
1997 • 572 citations
Hepatitis C Virus Genotypes in the United States: Epidemiology, Pathogenicity, and Response to Interferon Therapy
1996 • 391 citations
INTERFERON ALFA-2b ALONE OR IN COMBINATION WITH RIBAVIRIN FOR THE TREATMENT OF RELAPSE OF CHRONIC HEPATITIS C
1998 • 363 citations
A pilot study of combination therapy with ribavirin plus interferon alfa for interferon alfa-resistant chronic hepatitis C
1994 • 292 citations
10-year follow-up after interferon-? therapy for chronic hepatitis C
1998 • 279 citations
Long-term efficacy of ribavirin plus interferon alfa in the treatment of chronic hepatitis C
1996 • 253 citations
A pilot study of ribavirin and interferon beta for the treatment of chronic hepatitis C
1993 • 131 citations
The effect of interferon alfa and ribavirin combination therapy in naive patients with chronic hepatitis C.
1995 • 123 citations
Hepatitis C virus genotypes in France: relationship with epidemiology, pathogenicity and response to interferon therapy
1999 • 119 citations
LIVER TRANSPLANTATION FOR CHRONIC VIRAL HEPATITIS
1999 • 109 citations
A randomized trial of ribavirin and interferon-α vs. interferon-α alone in patients with chronic hepatitis C who were non-responders to a previous treatment
1999 • 84 citations
Interferon alpha-2b and ribavirin in combination for patients with chronic hepatitis C who failed to respond to, or relapsed after, interferon alpha therapy: a randomized trial
1999 • 73 citations
Ribavirin and interferon‐α combination therapy vs interferon‐α alone in the retreatment of chronic hepatitis C: a randomized clinical trial
1997 • 70 citations
Interferon-α-2B and ribavirin in combination for chronic hepatitis C patients not responding to interferon-α alone: an italian multicenter, randomized, controlled, clinical study
1998 • 64 citations
Sequential versus concomitant administration of ribavirin and interferon alfa-n3 in patients with chronic hepatitis C not responding to interferon alone: Results of a randomized, controlled trial
1998 • 54 citations
Chronic non‐A, non‐B hepatitis developed after transfusions, illicit self‐injections or sporadically. Outcome during long‐term follow‐up – a comparison
1989 • 52 citations
Treatment strategies for chronic hepatitis C: Update since the 1997 National Institutes of Health Consensus Development Conference
1999 • 49 citations
Combination antiviral therapy with ribavirin and interferon alfa in interferon alfa relapsers and non-responders: Italian experience.
1995 • 46 citations
Interferon-α plus ribavirin in chronic hepatitis C resistant to previous interferon-α course: results of a randomized multicenter trial
1999 • 45 citations
Treatment with Interferon-Alpha2a Alone or Interferon-Alpha2a plus Ribavirin in Patients with Chronic Hepatitis C Previously Treated with Interferon-Alpha2a
1999 • 42 citations
Retreatment of non-responder or relapser chronic hepatitis C patients with interferon plus ribavirin vs interferon alone.
1999 • 38 citations
Pilot study of a short course of ribavirin and alpha interferon in the treatment of chronic active hepatitis C not responding to alpha-interferon alone.
1996 • 35 citations
Interferon versus ribavirin plus interferon in chronic hepatitis C previously resistant to interferon: a randomized trial
1999 • 35 citations
Treatment of chronic hepatitis C with interferon alpha: long-term follow-up and prognostic relevance of HCV genotypes.
1996 • 27 citations
New treatment strategies in non-responder patients with chronic hepatitis C
1999 • 24 citations
Ribavirin plus human leucocyte interferon alpha for the treatment of interferon resistant chronic hepatitis C: a controlled trial
1997 • 14 citations
Ten year follow-up of patients with chronic hepatitis C treated with interferon.
1999 • 11 citations
Interferon treatment of HCV positive cirrhotic patients.
1998 • 4 citations
What to do when standard therapy fails.
2000 • 2 citations
Deleted Work
1955 • 0 citations
Cited By (0)
No citing papers found in database